Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated Political Action Committee (VPAC)

Corporate PAC FEC C00468660

Influence at a glance · Jan 2025 – Sep 2026Jan 25 – Sep 26 How we count

PAC giving to candidates$204K

Company lobbying, all issues $8.4M

Giving: FEC filings, net of refunds. Lobbying: the company’s own LD-2 reports, all issues, rounded to the nearest $10,000 each quarter. Two different filers, same 21 months.Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.

Lobbying spend by quarter since 2015Spend by quarter Pro

Free account See Pro

What they lobby on

Method

Vertex Pharmaceuticals reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 13 outside firms. What follows is what the filings say it lobbied on, not which way.

Issue areas ranked by quarters filedQ4 24 → Q3 26

Budget/Appropriations8 of 88/8
Health Issues8 of 88/8
Medical/Disease Research/Clinical Labs8 of 88/8
Medicare/Medicaid8 of 88/8
Taxation/Internal Revenue Code8 of 88/8

Defense 7 of 8 · Pharmacy 7 of 8 · 3 more · Show all 10

Defense7 of 87/8
Pharmacy7 of 87/8
Trade (domestic/foreign)7 of 87/8
Veterans4 of 84/8
District of Columbia1 of 81/8

Bills named in the filings 25 bills, this period

S. 475 / H.R. 1227 Alternatives to PAIN Act51 filings
S. 3832 / H.R. 7142, 118th Alternatives to PAIN Act7 filings
S. 864 / H.R. 6423 HELP Copays Act7 filings
H.R. 1414 Cameron’s Law6 filings
H.R. 1518 New Era of Preventing End-Stage Kidney Disease Act6 filings

20 more, 11 named in only one filing · Show all 25

H.R. 7142 ACE Agriculture Act5 filings
S. 3832 Small Business Workforce Pipeline Act of 20265 filings
S. 375 Transition-to-Success Mentoring Act3 filings
H.R. 1672 Maintaining Investments in New Innovation Act2 filings
H.R. 2484 Seniors’ Access to Critical Medications Act of 20252 filings
S. 1862 / H.R. 946 ORPHAN Cures Act2 filings
H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill2 filings
H.R. 3838 Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 Broad bill2 filings
S. 2296 National Defense Authorization Act for Fiscal Year 2026 Broad bill2 filings
H.R. 714, 118th Feral Swine Act1 filing
H.R. 7421, 118th McIntire-Stennis Act District of Columbia Equality Act1 filing
S. 1375 / H.R. 830, 118th HELP Copays Act1 filing
S. 2973, 118th On congress.gov1 filing
S. 891 Bipartisan Health Care Act1 filing
H.Con.Res. 14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Broad bill1 filing
H.R. 10545, 118th American Relief Act, 2025 Broad bill1 filing
H.R. 1968 Full-Year Continuing Appropriations and Extensions Act, 2025 Broad bill1 filing
H.R. 5378, 118th Lower Costs, More Transparency Act Broad bill1 filing
S. 127, 118th Pharmacy Benefit Manager Transparency Act of 2023 Broad bill1 filing
S. 1339, 118th Pharmacy Benefit Manager Reform Act Broad bill1 filing

From the filings

“Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.”

Q3 2026 filing · Medicare/Medicaid

“Access to innovative non-opioid medicines.”

Q3 2026 filing · Health Issues

Contacted as listed on the filings

U.S. House
U.S. Senate
Centers For Medicare and Medicaid ServicesCMS
Health & Human ServicesHHS
Congressional Budget OfficeCBO
Office of Management & BudgetOMB
White House Office
Food & Drug AdministrationFDA
U.S. Trade RepresentativeUSTR
Executive Office of the PresidentEOP
Vice President of the U.S.
CommerceDOC
4 more

The House and Senate appear in every quarter; agencies in all 8 quarters.

Every filing since 2015, with the lobbyists named and the quarters each bill appearsEvery filing since 2015 Pro

Free account See Pro

Source: Lobbying Disclosure Act filings (LD-2) by Vertex Pharmaceuticals, Senate Office of Public Records. Filings are due 20 days after each quarter ends.

From FEC filings: direct gifts this PAC reported, net of refunds · How we count

Gave directly to 66 sitting members of Congress in 2025–26.

Everyone this PAC fundsPro

See every candidate and member Vertex Pharmaceuticals gave to directly, how much, and how its money splits between the parties.

This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.

Create a free account See what Pro adds Log in